FDA accepts Takeda's oveporexton NDA with priority review for narcolepsy type 1
Eli Lilly signs definitive agreement to acquire Orna Therapeutics
CiteAb launches new scientific image search tool and improved reagent search engine
Innocan Pharma reports findings from clinical study of LPT-CBD in dogs
Lunai Bioworks starts new oncology collaboration with clinical-stage partner
BioArctic and Eisai secure Priority Review in China for subcutaneous Leqembi
Sanofi's rilzabrutinib receives FDA breakthrough and Japan orphan designations for rare anaemia
Kelun-Biotech reports fourth indication for sac-TMT approved by NMPA in HR+/HER2- breast cancer
Delonix Bioworks gets IND clearance for DX-104 in China
Innovent Biologics collaborates with Eli Lilly to develop new oncology and immunology treatments
Ascentage Pharma receives China IND clearance for BTK degrader APG‑3288
BioArctic reports higher royalties as Leqembi sales reach JPY20.7bn in Q4 2025
K36 Therapeutics completes first patient cohort dosing for Phase 1 trial of KTX-2001
Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban
Cizzle Biotechnology secures Canadian patent for lung cancer biomarker test